In humans, defects in the FasL–Fas signaling pathway result in the autoimmune lymphoproliferative syndrome (ALPS), which most often manifests as autoimmune hemolytic anemia or other cytopenias caused by cell-specific autoantibody production (14). This evidence concerns the gene FASLG and autoimmune lymphoproliferative syndrome.